Celldex Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $15.2M | $-36.9M | $-36.5M |
| FY2010 | $46.8M | $-6.5M | $-2.5M |
| FY2011 | $9.3M | $-43.4M | $-44.8M |
| FY2012 | $11.2M | $-58.1M | $-59.1M |
| FY2013 | $4.1M | $-81.4M | $-81.6M |
| FY2014 | $3.6M | $-122.4M | $-118.1M |
| FY2015 | $5.5M | $-129.5M | $-127.2M |
| FY2016 | $6.8M | $-132.9M | $-128.5M |
| FY2017 | $12.7M | $-121.5M | $-93.0M |
| FY2018 | $9.5M | $-156.4M | $-151.2M |
| FY2019 | $3.6M | $-55.0M | $-50.9M |
| FY2020 | $7.4M | $-63.4M | $-59.8M |
| FY2021 | $4.7M | $-71.2M | $-70.5M |
| FY2022 | $2.4M | $-115.2M | $-112.3M |
| FY2023 | $6.9M | $-154.5M | $-141.4M |
| FY2024 | $7.0M | $-195.1M | $-157.9M |
| FY2025 | $1.5M | $-287.4M | $-258.8M |